000 | 01977 a2200553 4500 | ||
---|---|---|---|
005 | 20250518012835.0 | ||
264 | 0 | _c20190528 | |
008 | 201905s 0 0 eng d | ||
022 | _a1558-2035 | ||
024 | 7 |
_a10.2459/JCM.0000000000000738 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFerrari, Marco | |
245 | 0 | 0 |
_aClopidogrel pharmacogenetics: associations between genotype and stent thrombosis risk in patients with stent placement. _h[electronic resource] |
260 |
_bJournal of cardiovascular medicine (Hagerstown, Md.) _c01 2019 |
||
300 |
_a46-48 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B _xgenetics |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aClopidogrel _xadministration & dosage |
650 | 0 | 4 |
_aCoronary Thrombosis _xetiology |
650 | 0 | 4 |
_aCytochrome P-450 CYP1A2 _xgenetics |
650 | 0 | 4 |
_aCytochrome P-450 CYP2B6 _xgenetics |
650 | 0 | 4 |
_aCytochrome P-450 CYP2C19 _xgenetics |
650 | 0 | 4 |
_aCytochrome P-450 CYP2C9 _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenetic Predisposition to Disease |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPercutaneous Coronary Intervention _xadverse effects |
650 | 0 | 4 | _aPharmacogenetics |
650 | 0 | 4 | _aPharmacogenomic Variants |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 | _aPilot Projects |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aStents |
700 | 1 | _aTozzi, Matteo | |
700 | 1 | _aMarino, Franca | |
700 | 1 | _aTarallo, Antonio | |
700 | 1 | _aRiva, Francesca | |
700 | 1 | _aMirabile, Mauro | |
700 | 1 | _aCastelli, Patrizio | |
700 | 1 | _aCosentino, Marco | |
773 | 0 |
_tJournal of cardiovascular medicine (Hagerstown, Md.) _gvol. 20 _gno. 1 _gp. 46-48 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2459/JCM.0000000000000738 _zAvailable from publisher's website |
999 |
_c29144857 _d29144857 |